Questions abound now that Donald Trump is headed back to the White House. One of particular import: What impact will his relationship with Robert F. Kennedy Jr. have on vaccines in the U.S.? We have a look at that question today, discuss another U.S. biotech launch using Chinese science, and more.
How RFK Jr.’s vaccine views could shape policy
President-elect Trump’s decision to entrust noted vaccine skeptic Robert F. Kennedy Jr. with responsibility for health policy has raised questions about whether they could reshape federal agencies to challenge or delay vaccine approvals and recommendations — and fan the flames of vaccine skepticism. While Kennedy isn’t necessarily expected to run a health agency himself, he could still play a major role in altering expert panels like the CDC’s Advisory Committee on Immunization Practices.
Kennedy could also undermine public confidence in vaccines through public statements, STAT’s Lizzy Lawrence and Timmy Broderick write.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
